Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study
Tiziana Pagano, Giuseppe De Placido, Roberta Vallone, G. Nazzaro, Pasquale De Rosa, Grazia Arpino(University of Naples Federico II), Alessandra Gallo, Mario Giuliano(Regione Campania), Sabino De Placido, Rossella Lauria, Alessandro Conforti(University of Naples Federico II), Mariavittoria Locci, Irene De Santo(University of Naples Federico II), Francesco Schettini(Target (United States))
Menopause The Journal of The North American Menopause Society
December 29, 2017
Cited by 76
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
|Endocrine Reviews|2008|545
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282